artificial intelligence (ai): transformation in gestational diabetes mellitus (gdm) treatment in india

Gestational diabetes mellitus (gdm) refers to a condition characterized by varying degrees of glucose intolerance, which is initially identified during pregnancy. it is typically identified by conducting screenings on pregnant women to assess their clinical risk factors. subsequently, among those deemed at risk, diagnostic tests are performed to evaluate their glucose tolerance. it is worth noting that women diagnosed with these diseases face an elevated likelihood of experiencing or developing diabetes outside of the pregnancy period. it refers to the occurrence of elevated blood glucose levels during pregnancy. the disease includes hyperglycaemia of varying degrees, ranging from pre-existing type 2 diabetes diagnosed during pregnancy to the development of full-blown gdm during pregnancy. it is associated with various adverse outcomes for both the mother and the new-born. these include increased birth weight and increased c-peptide levels in cord blood serum. in addition, having gestational diabetes puts you at a higher risk of developing diabetes in the future. the study's most important findings on awareness primarily affected respondents from cities -76.59%, in semi-urban areas it was 67.77% and in rural areas it was lowest -23.54%. the perception results show that the majority of respondents believe that ai has transformed healthcare services with lower costs and greater accuracy while providing other benefits.